Research Library — Receptor Combinations | Reta Compare
12 research articles in Receptor Combinations. Page 1 of 1.
Articles
- Exploring the Quad-Agonist Combination of GLP-1, GIP, Glucagon, and Amylin
- GLP-1 + GIP + Glucagon + FGF21: Enhancing Fatty Liver Activity
- GLP-1 + GIP + Glucagon + PYY/Y2: Enhancing Satiety through Multi-Agonism
- Exploring the Potential of a Quad-Agonist Combination: GLP-1, GIP, Glucagon, and GDF15
- GLP-1 and Amylin Dual Agonists: Implications for Quad-Agonist Development
- GLP-1 and Glucagon Dual Agonists: A Foundation for Future Triple and Quad Therapies
- GLP-1 + GIP + Glucagon Triple Agonists: Retatrutide as the Benchmark for Future Multi-Agonist Therapies
- Adding Amylin to Triple Agonists: Mechanistic Synergy Explained
- FGF21 and Incretin Combinations: Enhancing Hepatic and Metabolic Outcomes
- Y2 Receptor Agonism in Multi-Receptor Obesity Drugs
- Exploring the GDF15 Pathway in Next-Generation Obesity Drugs
- Activin/Myostatin Pathway as a Target in Next-Gen Obesity Drugs